Eli Lilly's R&D expenditure as a share of revenue 2010-2023
This statistic depicts the spending on research and development by Eli Lilly and Company, shown as a share of revenue from 2010 to 2023. In 2023, the company spent more than 27 percent of its revenues for R&D purposes. Eli Lilly and Company is an international pharmaceutical company, headquartered in Indianapolis, Indiana.